Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,172,442
+$758,284 QoQ
Shares Held
16,581
+5.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#1,427
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. ABBV ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,094 | $7,208,079 | |
| 2 | LLY |
ELI LILLY & Co
|
3,655 | $4,383,917 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
16,581 | $4,172,442 | |
| 4 | JNJ |
Johnson & Johnson
|
16,303 | $4,140,472 | |
| 5 | AMGN |
Amgen Inc
|
10,917 | $3,953,264 | |
| 6 | AZN |
Astrazeneca PLC
|
5,916 | $1,121,791 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,157 | $1,046,206 | |
| 8 | PFE |
Pfizer Inc
|
35,388 | $852,143 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,172,442 | 16,581 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,414,158 | 15,698 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,658,810 | 16,013 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,710,891 | 16,027 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,955,812 | 15,924 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,348,339 | 15,981 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,573,533 | 8,855 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,445,356 | 7,319 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,263,930 | 7,369 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,363,564 | 7,488 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,200,862 | 7,749 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,169,822 | 7,848 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,018,558 | 7,560 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,292,650 | 8,111 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,406,168 | 8,701 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $1,245,200 | 9,278 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,376,908 | 8,990 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,453,964 | 8,969 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,016,177 | 7,505 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $835,345 | 7,744 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $888,616 | 7,889 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $870,954 | 8,048 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $867,486 | 8,096 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $690,997 | 7,889 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $780,531 | 7,950 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $665,595 | 8,736 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||